Hypersensitivity of tumor cell lines with microsatellite instability to DNA double strand break producing chemotherapeutic agent bleomycin

Cancer Research

Volumn 64, Issue 14, 2004, Pages 4760-4767

  Li, Hai Ri ^a   Shagisultanova, Elena I ^a   Yamashita, Kentaro ^a   Piao, Zhe ^a   Perucho, Manuel ^a   Malkhosyan, Sergei R ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BLEOMYCIN; DOUBLE STRANDED DNA; PROTEIN KINASE INHIBITOR;

ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL GROWTH; CELL STRAIN HCT 8; CELL SURVIVAL; CHEMOSENSITIVITY; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA DOUBLE STRAND BREAKAGE; DNA DOUBLE STRAND BREAKAGE REPAIR GENE; DNA REPAIR; DNA STRAND BREAKAGE; DRUG HYPERSENSITIVITY; ENDOMETRIUM CANCER; FRAMESHIFT MUTATION; GENE; GENE INACTIVATION; GENE MUTATION; GROWTH REGULATION; HUMAN; HUMAN CELL; MICROSATELLITE INSTABILITY; MICROSATELLITE MUTATOR PHENOTYPE; MISMATCH REPAIR; OVARY CANCER; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER;

ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; CELL LINE, TUMOR; DNA DAMAGE; DNA REPAIR; DNA, NEOPLASM; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; FRAMESHIFT MUTATION; GENES, P53; HUMANS; MICROSATELLITE REPEATS; NEOPLASMS; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES;

EID: 3142658762     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0975     Document Type: Article

References (63)

1. Jiricny J, Marra G. DNA repair defects in colon cancer. Curr Opin Genet Dev 2003;13:61-9.
2. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science (Wash D C) 1993;260:816-9.
3. Perucho M. Cancer of the microsatellite mutator phenotype. Biol Chem. 1996;377: 675-84.
4. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature (Lond) 1993;363:558-61.
5. Duval A, Hamelin R. Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability. Cancer Res 2002;62:2447-54.
6. Woerner SM, Benner A, Sutter C, et al. Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative Real Common Target genes. Oncogene 2003;22:2226-35.
7. Fink D, Aebi S, Howell SB. The role of DNA mismatch repair in drug resistance. Clin Cancer Res 1998;4:1-6.
8. Prolla TA, Baker SM, Harris AC, et al. Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. Nat Genet 1998;18:276-9.
9. de Wind N, Dekker M, Claij N, et al. HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3 and Msh6 mismatch-repair protein functions. Nat Genet 1999;23:359-62.
10. Zhang H, Richards B, Wilson T, et al. Apoptosis induced by overexpression of hMSH2 of hMLH1. Cancer Res 1999;59:3021-7.
11. Shimodaira H, Yoshioka-Yamashita A, Kolodner RD, Wang JY. Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin. Proc Natl Acad Sci USA 2003;100:2420-5.
12. Rampino N, Yamamoto H, Ionov Y, et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science (Wash D C) 1997;275:967-9.
13. Yamamoto H, Gil J, Schwartz SJ, Perucho M. Frameshift mutations in Fas, Apaf-1, and Bcl-10 in gastro-intestinal cancer of the microsatellite mutator phenotype. Cell Death Differ 2000;7:238-9.
14. Yamamoto H, Sawai H, Perucho M. Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res 1997;57:4420-6.
15. Ikenoue T, Togo G, Nagai K, et al. Frameshift mutations at mononucleotide repeats in RAD50 recombinational DNA repair gene in colorectal cancers with microsatellite instability. Jpn J Cancer Res 2001;92:587-91.
16. Kim NG, Choi YR, Baek MJ, et al. Frameshift mutations at coding mononucleotide repeats of the hRAD50 gene in gastrointestinal carcinomas with microsatellite instability. Cancer Res 2001;61:36-8.
17. Giannini G, Ristori E, Cerignoli F, et al. Human MRE11 is inactivated in mismatch repair-deficient cancers. EMBO Rep 2002;3:248-54.
18. Liu B, Parsons RE, Hamilton SR, et al. hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res 1994;54:4590-4.
19. Shibata D, Peinado MA, Ionov Y, Malkhosyan S, Perucho M. Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nat Genet 1994;6:273-81.
20. Schwartz SJ, Yamamoto H, Navarro M, et al. Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res 1999;59:2995-3002.
21. Suter CM, Norrie M, Ku SL, et al. CpG island methylation is a common finding in colorectal cancer cell lines. Br J Cancer 2003;88:413-9.
22. Malkhosyan S, Rampino N, Yamamoto H, Perucho M. Frameshift mutator mutations. Nature (Lond) 1996;382:499-500.
23. Cottu PH, Muzeau F, Estreicher A, et al. Inverse correlation between RER+ status and p53 mutation in colorectal cancer cell lines. Oncogene 1996;13:2727-30.
24. Boyer JC, Umar A, Risinger JI, et al. Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines. Cancer Res 1995;55:6063-70.
25. Umar A, Boyer JC, Thomas DC, et al. Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability. J Biol Chem 1994;269:14367-70.
26. Soga S, Neckers LM, Schulte TW, et al. KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling molecules. Cancer Res 1999;59:2931-8.
27. Chen Y, Wang J, Fraig MM, et al. Defects of DNA mismatch repair in human prostate cancer. Cancer Res 2001;61:4112-21.
28. Smirnova IS, Yakovleva TK, Rosanov YM, Aksenov ND, Pospelova TV. Analysis of p53-dependent mechanisms in the maintenance of genetic stability in diploid tumourigenic line SK-UT-1B of human uterine leiomyosarcoma. Cell Biol Int 2001;25:1101-15.
29. Risinger JI, Umar A, Boyer JC, et al. Microsatellite instability in gynecological sarcomas and in hMSH2 mutant uterine sarcoma cell lines defective in mismatch repair activity. Cancer Res 1995;55:5664-9.
30. da Costa LT, Liu B, el-Deiry W, et al. Polymerase delta variants in RER colorectal tumours. Nat Genet 1995;9:10-1.
31. Bunz F, Dutriaux A, Lengauer C, et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science (Wash D C) 1998;282:1497-501.
32. Papadopoulos N, Nicolaides NC, Wei YF, et al. Mutation of a mutL homolog in hereditary colon cancer. Science (Wash D C) 1994;263:1625-9.
33. Ohmiya N, Matsumoto S, Yamamoto H, et al. Germline and somatic mutations in hMSH6 and hMSH3 in gastrointestinal cancers of the microsatellite mutator phenotype. Gene 2001;272:301-13.
34. Kane MF, Loda M, Gaida GM, et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 1997;57:808-11.
35. Rodrigues NR, Rowan A, Smith ME, et al. p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 1990;87:7555-9.
36. Papadopoulos N, Nicolaides NC, Liu B, et al. Mutations of GTBP in genetically unstable cells. Science (Wash D C) 1995;268:1915-7.
37. Matsui SI, Arredondo MA, Wrzosek C, Rustum YM. DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells. Cancer Res 1996;56:4715-23.
38. Yamamoto H, Perez-Piteira J, Yoshida T, et al. Gastric cancers of the microsatellite mutator phenotype display characteristic genetic and clinical features. Gastroenterology 1999;116:1348-57.
39. Baranovskaya S, Soto JL, Perucho M, Malkhosyan SR. Functional significance of concomitant inactivation of hMLH1 and hMSH6 in tumor cells of the microsatellite mutator phenotype. Proc Natl Acad Sci USA 2001;98:15107-12.
40. Vlahos CJ, Matter WF, Hui KY, Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 1994;269:5241-8.
41. Mir LM, Tounekti O, Orlowski S. Bleomycin: revival of an old drug. Gen Pharmacol 1996;27:745-8.
42. Tounekti O, Kenani A, Foray N, Orlowski S, Mir LM. The ratio of single- to double-strand DNA breaks and their absolute values determine cell death pathway. Br J Cancer 2001;84:1272-9.
43. Davis TW, Wilson-Van Patten C, Meyers M, et al. Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiation. Cancer Res 1998;58:767-78.
44. Yan T, Schupp JE, Hwang HS, et al. Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiation. Cancer Res 2001;61:8290-7.
45. Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 2001;27:247-54.
46. Smith GC, Jackson SP. The DNA-dependent protein kinase. Genes Dev 1999;13: 916-34.
47. Orelli BJ, Bishop DK. BRCA2 and homologous recombination. Breast Cancer Res 2001;3:294-8.
48. Wang Y, Cortez D, Yazdi P, et al. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 2000;14:927-39.
49. Wright JA, Keegan KS, Herendeen DR, et al. Protein kinase mutants of human ATR increase sensitivity to UV and ionizing radiation and abrogate cell cycle checkpoint control. Proc Natl Acad Sci USA 1998;95:7445-50.
50. Menoyo A, Alazzouzi H, Espin E, et al. Somatic mutations in the DNA damage-response genes ATR and CHK1 in sporadic stomach tumors with microsatellite instability. Cancer Res 2001;61:7727-30.
51. Allalunis-Turner MJ, Zia PK, Barron GM, Mirzayans R, Day RS, 3rd. Radiation-induced DNA damage and repair in cells of a radiosensitive human malignant glioma cell line. Radiat Res 1995;144:288-93.
52. Nussenzweig A, Chen C, da Costa Soares V, et al. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature (Lond) 1996;382:551-5.
53. Ouyang H, Nussenzweig A, Kurimasa A, et al. Ku70 is required for DNA repair but not for T cell antigen receptor gene recombination In vivo. J Exp Med 1997;186: 921-9.
54. Smider V, Rathmell WK, Lieber MR, Chu G. Restoration of X-ray resistance and V(D)J recombination in mutant cells by Ku cDNA. Science (Wash D C) 1994;266: 288-91.
55. Omori S, Takiguchi Y, Suda A, et al. Suppression of a DNA double-strand break repair gene, Ku70, increases radio- and chemosensitivity in a human lung carcinoma cell line. DNA Repair (Amst) 2002;1:299-310.
56. Hosoi Y, Miyachi H, Matsumoto Y, et al. A phosphatidylinositol 3-kinase inhibitor wortmannin induces radioresistant DNA synthesis and sensitizes cells to bleomycin and ionizing radiation. Int J Cancer 1998;78:642-7.
57. Rosenzweig KE, Youmell MB, Palayoor ST, Price BD. Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay. Clin Cancer Res 1997;3:1149-56.
58. Vermeulen SJ, Chen TR, Speleman F, et al. Did the four human cancer cell lines DLD-1, HCT-15, HCT-8, and HRT-18 originate from one and the same patient? Cancer Genet Cytogenet 1998;107:76-9.
59. Rich T, Allen RL, Wyllie AH. Defying death after DNA damage. Nature (Lond) 2000;407:777-83.
60. Umar A, Koi M, Risinger JI, et al. Correction of hypermutability, N-methyl-N′-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. Cancer Res 1997;57:3949-55.
61. Malkhosyan S, McCarty A, Sawai H, Perucho M. Differences in the spectrum of spontaneous mutations in the hprt gene between tumor cells of the microsatellite mutator phenotype. Mutat Res 1996;316:249-59.
62. Lee JM, Bernstein A. p53 mutations increase resistance to ionizing radiation. Proc Natl Acad Sci USA 1993;90:5742-6.
63. Suzuki K, Dai T, Suzuki I, et al. Low mutation incidence in polymorphic noncoding short mononucleotide repeats in gastrointestinal cancer of the microsatellite mutator phenotype pathway. Cancer Res 2002;62:1961-5.